Abstract:Hereditary spastic paraplegia (HSP) denotes genetically heterogeneous disorders characterized by leg spasticity due to degeneration of corticospinal axons. SPG11 and SPG15 have a similar clinical course and together are the most prevalent autosomal recessive HSP entity. The respective proteins play a role for macroautophagy/autophagy and autophagic lysosome reformation (ALR). Here, we report that spg11 and zfyve26 KO mice developed motor impairments within the same course of time. This correlated with enhanced accumulation of autofluorescent material in neurons and progressive neuron loss. In agreement with defective ALR, tubulation events were diminished in starved KO mouse embryonic fibroblasts (MEFs) and lysosomes decreased in neurons of KO brain sections. Confirming that both proteins act in the same molecular pathway, the pathologies were not aggravated upon simultaneous disruption of both. We further show that PI4K2A (phosphatidylinositol 4-kinase type 2 alpha), which phosphorylates phosphatidylinositol to phosphatidylinositol-4-phosphate (PtdIns4P), accumulated in autofluorescent deposits isolated from KO but not WT brains. Elevated PI4K2A abundance was already found at autolysosomes of neurons of presymptomatic KO mice. Immunolabelings further suggested higher levels of PtdIns4P at LAMP1-positive structures in starved KO MEFs. An increased association with LAMP1-positive structures was also observed for clathrin and DNM2/dynamin 2, which are important effectors of ALR recruited by phospholipids. Because PI4K2A overexpression impaired ALR, while its knockdown increased tubulation, we conclude that PI4K2A modulates phosphoinositide levels at autolysosomes and thus the recruitment of downstream effectors of ALR. Therefore, PI4K2A may play an important role in the pathogenesis of SPG11 and SPG15.Abbreviations: ALR: autophagic lysosome reformation; AP-5: adaptor protein complex 5; BFP: blue fluorescent protein; dKO: double knockout; EBSS: Earle's balanced salt solution; FBA: foot base angle; GFP: green fluorescent protein; HSP: hereditary spastic paraplegia; KO: knockout; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3B/LC3: microtubule-associated protein 1 light chain 3 beta; MEF: mouse embryonic fibroblast; SQSTM1/p62: sequestosome 1; PI4K2A: phosphatidylinositol 4-kinase type 2 alpha; PtdIns3P: phosphatidylinositol-3-phosphate; PtdIns4P: phosphatidylinositol-4-phosphate; RFP: red fluorescent protein; SPG: spastic paraplegia gene; TGN: trans-Golgi network; WT: wild type

Cul-4 inhibition rescues spastin levels and reduces defects in hereditary spastic paraplegia models

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

FBXL17/spastin axis as a novel therapeutic target of hereditary spastic paraplegia

Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons

Unraveling Isoform Complexity: The Roles of M1‐ and M87‐Spastin in Spastic Paraplegia 4 (SPG4)

A Novel SPAST Mutation Results in Spastin Accumulation and Defects in Microtubule Dynamics

Mutation of Spastin Affects Microtubule Dynamics Through Differential Distribution

Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis

Spastin regulates ER-mitochondrial contact sites and mitochondrial homeostasis

Mouse models for hereditary spastic paraplegia uncover a role of PI4K2A in autophagic lysosome reformation

14-3-3 protein augments the protein stability of phosphorylated spastin and promotes the recovery of spinal cord injury through its agonist intervention

Inhibition of spastin impairs motor function recovery after spinal cord injury

A major disease-related point mutation in spastin alters dramatically the dynamics and allostery of the motor

Axon demyelination and degeneration in a zebrafish spastizin model of hereditary spastic paraplegia

Molecular and Cellular Mechanisms of Spastin in Neural Development and Disease (Review)

SPAST Intragenic CNVs Lead to Hereditary Spastic Paraplegia via a Haploinsufficiency Mechanism

Progress of pathogenesis of hereditary spastic paraplegia type 4

Pluripotent Stem Cells as a Preclinical Cellular Model for Studying Hereditary Spastic Paraplegias

Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3

Spastin Interacts with Collapsin Response Mediator Protein 3 to Regulate Neurite Growth and Branching

Loss of Fic causes progressive neurodegeneration in a Drosophila model of hereditary spastic paraplegia